PFIZER INC
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Mailing Address
66 HUDSON BOULEVARD EAST, NEW YORK, NY, 10001-2192
Phone
2127332323
Fiscal Year End
1231
EIN
135315170
Financial Overview
FY2025
$8.03B
Net Income
$88.20B
Stockholders' Equity
$1.14B
Cash & Equivalents
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | April 1, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| 4 Insider stock transaction report | March 30, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | March 27, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| DEF 14A Definitive proxy statement | March 12, 2026 | View on SEC |
Annual Reports
10-K
February 26, 2026
- Strategic pivot to oncology via $43 billion Seagen acquisition, strengthening pipeline and adding over $3 billion revenue in 2024.
- Achieved approximately 7% operational growth in core biopharma products (excluding COVID-19) despite overall revenue decline.
Material Events
8-K
Strategy Change
December 16, 2025
High Impact
- Pfizer updated its financial outlook, narrowing 2025 revenue guidance to approximately $62.0 billion while reaffirming 2025 Adjusted Diluted EPS guidance.
- New 2026 forecasts project revenues of $59.5 billion to $62.5 billion and Adjusted Diluted EPS of $2.80 to $3.00.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.